March 2021

Allen JD, Ross TM. Next generation methodology for updating HA vaccines against emerging human seasonal influenza A(H3N2) viruses. Sci Rep. 2021;11(1):4554. Published 2021 Mar 2. doi:10.1038/s41598-020-79590-7
Full text

Baral SD, Rucinski KB, Twahirwa Rwema JO, et al. The Relationship Between the Global Burden of Influenza From 2017 to 2019 and COVID-19: Descriptive Epidemiological Assessment. JMIR Public Health Surveill. 2021;7(3):e24696. Published 2021 Mar 2. doi:10.2196/24696
Full text

Hayashi T, Konishi I. Significant Decrease in Seasonal Influenza in the COVID-19 Era: Impact of Global Movement Restrictions?. J Clin Med Res. 2021;13(3):191-194. doi:10.14740/jocmr4450
Full text

Hu PJ, Chen CH, Wong CS, Chen TT, Wu MY, Sung LC. Influenza vaccination reduces incidence of peripheral arterial occlusive disease in elderly patients with chronic kidney disease. Sci Rep. 2021;11(1):4847. Published 2021 Mar 1. doi:10.1038/s41598-021-84285-8
Full text

Lafond KE, Porter RM, Whaley MJ, et al. Global burden of influenza-associated lower respiratory tract infections and hospitalizations among adults: A systematic review and meta-analysis. PLoS Med. 2021;18(3):e1003550. Published 2021 Mar 1. doi:10.1371/journal.pmed.1003550
Full text

Leung NHL. Transmissibility and transmission of respiratory viruses [published online ahead of print, 2021 Mar 22]. Nat Rev Microbiol. 2021;1-18. doi:10.1038/s41579-021-00535-6
Full text

Li Y, Wang LL, Xie LL, Hou WL, Liu XY, Yin S. The epidemiological and clinical characteristics of the hospital-acquired influenza infections: A systematic review and meta-analysis. Medicine (Baltimore). 2021;100(11):e25142. doi:10.1097/MD.0000000000025142
Full text

Liu L, Zeng F, Rao J, et al. Comparison of Clinical Features and Outcomes of Medically Attended COVID-19 and Influenza Patients in a Defined Population in the 2020 Respiratory Virus Season. Front Public Health. 2021;9:587425. Published 2021 Mar 23. doi:10.3389/fpubh.2021.587425
Full text

Oshansky CM, King J, Lu D, et al. Adjuvanted recombinant hemagglutinin H7 vaccine to highly pathogenic influenza A(H7N9) elicits high and sustained antibody responses in healthy adults. NPJ Vaccines. 2021;6(1):41. Published 2021 Mar 19. doi:10.1038/s41541-021-00287-7
Full text

Osman M, Klopfenstein T, Belfeki N, Gendrin V, Zayet S. A Comparative Systematic Review of COVID-19 and Influenza. Viruses. 2021;13(3):452. Published 2021 Mar 10. doi:10.3390/v13030452
Full text

Tasker S, Wight O'Rourke A, Suyundikov A, et al. Safety and Immunogenicity of a Novel Intranasal Influenza Vaccine (NasoVAX): A Phase 2 Randomized, Controlled Trial. Vaccines (Basel). 2021;9(3):224. Published 2021 Mar 5. doi:10.3390/vaccines9030224
Full text

 

February 2021

Carniel BF, Marcon F, Rylance J, et al. Pneumococcal colonization impairs mucosal immune responses to live attenuated influenza vaccine. JCI Insight. 2021;6(4):e141088. Published 2021 Feb 22. doi:10.1172/jci.insight.141088
Full text

Conlon A, Ashur C, Washer L, Eagle KA, Hofmann Bowman MA. Impact of the influenza vaccine on COVID-19 infection rates and severity [published online ahead of print, 2021 Feb 22]. Am J Infect Control. 2021;S0196-6553(21)00089-4. doi:10.1016/j.ajic.2021.02.012
Full text

Fens T, Boer PT, Puijenbroek EPV, Postma MJ. Inclusion of Safety-Related Issues in Economic Evaluations for Seasonal Influenza Vaccines: A Systematic Review. Vaccines (Basel). 2021;9(2):111. Published 2021 Feb 2. doi:10.3390/vaccines9020111
Full text

Huang QS, Wood T, Jelley L, Jennings T, Jefferies S, Daniells K, Nesdale A, Dowell T, Turner N, Campbell-Stokes P, Balm M, Dobinson HC, Grant CC, James S, Aminisani N, Ralston J, Gunn W, Bocacao J, Danielewicz J, Moncrieff T, McNeill A, Lopez L, Waite B, Kiedrzynski T, Schrader H, Gray R, Cook K, Currin D, Engelbrecht C, Tapurau W, Emmerton L, Martin M, Baker MG, Taylor S, Trenholme A, Wong C, Lawrence S, McArthur C, Stanley A, Roberts S, Rahnama F, Bennett J, Mansell C, Dilcher M, Werno A, Grant J, van der Linden A, Youngblood B, Thomas PG; NPIsImpactOnFlu Consortium, Webby RJ. Impact of the COVID-19 nonpharmaceutical interventions on influenza and other respiratory viral infections in New Zealand. Nat Commun. 2021 Feb 12;12(1):1001. doi: 10.1038/s41467-021-21157-9. PMID: 33579926; PMCID: PMC7881137.
Full text

Li APY, Cohen CA, Leung NHL, et al. Immunogenicity of standard, high-dose, MF59-adjuvanted, and recombinant-HA seasonal influenza vaccination in older adults. NPJ Vaccines. 2021;6(1):25. Published 2021 Feb 16. doi:10.1038/s41541-021-00289-5
Full text

Li Z, Zhong L, He J, Huang Y, Zhao Y. Development and application of reverse genetic technology for the influenza virus [published online ahead of print, 2021 Feb 2]. Virus Genes. 2021;1-13. doi:10.1007/s11262-020-01822-9
Full text

Koichi Miyashita, Eiji Nakatani, Hironao Hozumi, Yoko Sato, Yoshiki Miyachi, Takafumi Suda
Risk Factors for Pneumonia and Death in Adult Patients With Seasonal Influenza and Establishment of Prediction Scores: A Population-Based Study
Open Forum Infectious Diseases, Volume 8, Issue 3, March 2021, ofab068, https://doi.org/10.1093/ofid/ofab068
Full text

Okoli GN, Florentin Racovitan, Tiba Abdulwahid, Syed K Hyder, Louise Lansbury, Christiaan H Righolt, Salaheddin M Mahmud, Jonathan S Nguyen-Van-Tam. Decline in Seasonal Influenza Vaccine Effectiveness With Vaccination Program Maturation: A Systematic Review and Meta-analysis, Open Forum Infectious Diseases, Volume 8, Issue 3, March 2021, ofab069, https://doi.org/10.1093/ofid/ofab069
Full text

Qi L, Liu T, Gao Y, et al. Effect of meteorological factors on the activity of influenza in Chongqing, China, 2012-2019. PLoS One. 2021;16(2):e0246023. Published 2021 Feb 3. doi:10.1371/journal.pone.0246023
Full text

Roller-Wirnsberger R, Lindner S, Kolosovski L, et al. The role of health determinants in the influenza vaccination uptake among older adults (65+): a scope review [published online ahead of print, 2021 Feb 15]. Aging Clin Exp Res. 2021;1-10. doi:10.1007/s40520-021-01793-3
Full text

Shim SJ, Chan M, Owens L, Jaffe A, Prentice B, Homaira N. Rate of use and effectiveness of oseltamivir in the treatment of influenza illness in high-risk populations: A systematic review and meta-analysis. Health Sci Rep. 2021;4(1):e241. Published 2021 Feb 10. doi:10.1002/hsr2.241
Full text

Tsuneki-Tokunaga A, Kanai K, Itagaki A, et al. Growth capability of epidemic influenza viruses in Japan since the 2009 H1N1 pandemic. Arch Virol. 2021;166(4):1193-1196. doi:10.1007/s00705-021-04976-5
Full text https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7880649/

Woo, EJ, Pedro L.Morob, PL. Postmarketing safety surveillance of quadrivalent recombinant influenza vaccine: Reports to the vaccine adverse event reporting system. Vaccine 5 March 2021 https://doi.org/10.1016/j.vaccine.2021.02.052
Abstract

Yin H, Jiang N, Shi W, et al. Development and Effects of Influenza Antiviral Drugs. Molecules. 2021;26(4):810. Published 2021 Feb 4. doi:10.3390/molecules26040810
Full text

 

January 2021

Chin J, Zhou Y, Chen CL, Lomiguen CM, McClelland S, Lee-Wong M. Influenza Vaccination Quality Improvement as a Model for COVID-19 Prophylaxis. Cureus. 2021;13(1):e12549. Published 2021 Jan 7. doi:10.7759/cureus.12549
Full text

Kassianos G, Banerjee A, Baron-Papillon F, et al. Key policy and programmatic factors to improve influenza vaccination rates based on the experience from four high-performing countries. Drugs Context. 2021;10:2020-9-5. Published 2021 Jan 5. doi:10.7573/dic.2020-9-5
Full text

Kumar S, Xu C, Ghildayal N, Chandra C, Yang M. Social media effectiveness as a humanitarian response to mitigate influenza epidemic and COVID-19 pandemic [published online ahead of print, 2021 Jan 29]. Ann Oper Res. 2021;1-29. doi:10.1007/s10479-021-03955-y
Full text

Li P, Hayat K, Jiang M, et al. Impact of video-led educational intervention on the uptake of influenza vaccine among adults aged 60 years and above in China: a study protocol for a randomized controlled trial. BMC Public Health. 2021;21(1):222. Published 2021 Jan 27. doi:10.1186/s12889-021-10220-1
Full text

McMillan CLD, Young PR, Watterson D, Chappell KJ. The Next Generation of Influenza Vaccines: Towards a Universal Solution. Vaccines (Basel). 2021;9(1):26. Published 2021 Jan 7. doi:10.3390/vaccines9010026
Full text

Schmader KE, Liu CK, Harrington T, et al. Safety, Reactogenicity, and Health-Related Quality of Life After Trivalent Adjuvanted vs Trivalent High-Dose Inactivated Influenza Vaccines in Older Adults: A Randomized Clinical Trial. JAMA Netw Open. 2021;4(1):e2031266. Published 2021 Jan 4. doi:10.1001/jamanetworkopen.2020.31266
Full text

Shi X, Chen M, Zhang Y. The cardiovascular disorders and prognostic cardiac biomarkers in COVID-19 [published online ahead of print, 2021 Jan 22]. Mol Biol Rep. 2021;1-9. doi:10.1007/s11033-021-06148-9
Full text

Sparrow E, Wood JG, Chadwick C, et al. Global production capacity of seasonal and pandemic influenza vaccines in 2019. Vaccine. 2021;39(3):512-520. doi:10.1016/j.vaccine.2020.12.018
Full text

Wiemken TL, Rutschman AS. Development of vaccines for influenza disease: Opportunity costs of the COVID-19 pandemic. Vaccine. 2021;39(7):1025-1026. doi:10.1016/j.vaccine.2021.01.014
Full text

Zhang C, Cui H, Wang Z, et al. Pathogenicity and transmissibility assessment of two strains of human influenza virus isolated in China in 2018. J Int Med Res. 2021;49(1):300060520982832. doi:10.1177/0300060520982832
Full text

Zhu W, Dong C, Wei L, Wang BZ. Promising Adjuvants and Platforms for Influenza Vaccine Development. Pharmaceutics. 2021;13(1):68. Published 2021 Jan 7. doi:10.3390/pharmaceutics13010068
Full text 

 

December 2020

Chen X, Wang W, Wang Y, et al. Serological evidence of human infections with highly pathogenic avian influenza A(H5N1) virus: a systematic review and meta-analysis. BMC Med. 2020;18(1):377. Published 2020 Dec 2. doi:10.1186/s12916-020-01836-y
Full text

Khan MS, Shahid I, Stefan D, Anker SD. et al. Cardiovascular implications of COVID-19 versus influenza infection: a review. BMC Med. 2020; 18: 403.  Published online 2020 Dec 18. doi: 10.1186/s12916-020-01816-2
Full text

Lu L, Fong CH, Zhang AJ, et al. Repurposing of Miltefosine as an Adjuvant for Influenza Vaccine. Vaccines (Basel). 2020;8(4):754. Published 2020 Dec 11. doi:10.3390/vaccines8040754
Full text

Mudd PA, Crawford JC, Turner JS, et al. Distinct inflammatory profiles distinguish COVID-19 from influenza with limited contributions from cytokine storm. Sci Adv. 2020;6(50):eabe3024. Published 2020 Dec 9. doi:10.1126/sciadv.abe3024
Full text

Olsen SJ, Azziz-Baumgartner E, Budd AP, et al. Decreased influenza activity during the COVID-19 pandemic-United States, Australia, Chile, and South Africa, 2020. Am J Transplant. 2020;20(12):3681-3685. doi:10.1111/ajt.16381
Full text

Sharma Y, Horwood C, Hakendorf P, Thompson C. Clinical characteristics and outcomes of influenza A and B virus infection in adult Australian hospitalised patients. BMC Infect Dis. 2020; 20: 913. Published online 2020 Dec 1. doi: 10.1186/s12879-020-05670-8
Full text

Schumacher S, Salmanton-García J, Cornely OA, Mellinghoff SC. Increasing influenza vaccination coverage in healthcare workers: a review on campaign strategies and their effect [published online ahead of print, 2020 Dec 7]. Infection. 2020;1-13. doi:10.1007/s15010-020-01555-9
Full text

Zhao X, Gang X, He G, et al. Obesity Increases the Severity and Mortality of Influenza and COVID-19: A Systematic Review and Meta-Analysis. Front Endocrinol (Lausanne). 2020;11:595109. Published 2020 Dec 21. doi:10.3389/fendo.2020.595109
Full text

 

(Updated 28 April 2021)